Sunny Optical Technology Revenue 2019-2024 | SNPTF

Sunny Optical Technology annual/quarterly revenue history and growth rate from 2019 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Sunny Optical Technology revenue for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Sunny Optical Technology revenue for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Sunny Optical Technology annual revenue for 2024 was $5.327B, a 18.99% increase from 2023.
  • Sunny Optical Technology annual revenue for 2023 was $4.477B, a 9.25% decline from 2022.
  • Sunny Optical Technology annual revenue for 2022 was $4.933B, a 15.07% decline from 2021.
Sunny Optical Technology Annual Revenue
(Millions of US $)
2024 $5,327
2023 $4,477
2022 $4,933
2021 $5,808
2020 $5,506
2019 $5,477
2018 $3,918
2017 $3,323
2016 $2,200
2015 $1,718
Sunny Optical Technology Quarterly Revenue
(Millions of US $)
2024-12-31
2024-06-30
2023-12-31
2023-06-30
2022-12-31
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2019-06-30
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $9.589B $5.327B
Sunny Optical Technology Group Co., Limited is engaged in the design, research and development, manufacture and sales of optical and optical-related products. Optical components product includes glass spherical and aspherical lenses, plane products, handset lens sets, vehicle lens sets and other various lens sets. Optoelectronic products includes handset camera modules, three-dimensional optoelectronic products, security cameras and other optoelectronic modules and optical instruments includes microscopes, optical measuring instruments and various high-end optical analytical instrument. Sunny Optical Technology Group Co., Limited is based in Yuyao, the People's Republic of China.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $217.359B 25.05
EssilorLuxottica (ESLOY) France $151.069B 0.00
Boston Scientific (BSX) United States $138.964B 31.78
Stryker (SYK) United States $137.439B 27.29
Medtronic (MDT) Ireland $126.586B 17.54
Medline (MDLN) United States $57.028B 0.00
Lonza Group Ag (LZAGY) Switzerland $48.992B 0.00
Agilent Technologies (A) United States $41.368B 26.15
GE HealthCare Technologies (GEHC) United States $38.856B 18.58
ResMed (RMD) United States $37.873B 26.21
Koninklijke Philips (PHG) Netherlands $28.984B 18.93
Terumo (TRUMY) Japan $21.172B 23.83
Insulet (PODD) United States $19.900B 61.77
Zimmer Biomet Holdings (ZBH) United States $17.686B 11.03
Smith & Nephew SNATS (SNN) United Kingdom $13.986B 0.00
Baxter (BAX) United States $10.199B 8.23
Bio-Rad Laboratories (BIO) United States $8.585B 30.87
Demant (WILYY) Denmark $7.372B 0.00
Lantheus Holdings (LNTH) United States $4.350B 13.25
BillionToOne (BLLN) United States $4.319B 0.00
Envista Holdings (NVST) United States $3.979B 22.83
ICU Medical (ICUI) United States $3.666B 23.28
Haemonetics (HAE) United States $3.545B 15.78
Prestige Consumer Healthcare (PBH) United States $3.115B 14.21
Shandong Weigao Medical Polymer (SHWGF) China $3.099B 0.00
QuidelOrtho (QDEL) United States $2.333B 15.00
Perrigo (PRGO) Ireland $2.045B 5.12
Neogen (NEOG) United States $2.043B 44.71
LeMaitre Vascular (LMAT) United States $1.939B 39.02
Curaleaf Holdings (CURLF) Canada $1.866B 0.00
AtriCure (ATRC) United States $1.858B 0.00
Green Thumb Industries (GTBIF) United States $1.734B 76.00
Phibro Animal Health (PAHC) United States $1.616B 16.14
Lumexa Imaging Holdings (LMRI) United States $1.471B 0.00
AdaptHealth (AHCO) United States $1.427B 20.67
Kestra Medical Technologies (KMTS) United States $1.302B 0.00
BioLife Solutions (BLFS) United States $1.170B 347.00
Capricor Therapeutics (CAPR) United States $1.133B 0.00
Tilray Brands (TLRY) Canada $1.112B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.007B 0.00
Omeros (OMER) United States $0.927B 0.00
Valneva SE (VALN) France $0.893B 0.00
InMode (INMD) Israel $0.887B 10.03
CeriBell (CBLL) United States $0.851B 0.00
VAREX IMAGING (VREX) United States $0.573B 15.55
Cerus (CERS) United States $0.526B 0.00
Cresco Labs (CRLBF) United States $0.486B 0.00
Verano Holdings (VRNO) United States $0.483B 0.00
Brainsway (BWAY) Israel $0.461B 78.50
Canopy Growth (CGC) Canada $0.450B 0.00
SNDL (SNDL) Canada $0.428B 0.00
Quanterix (QTRX) United States $0.343B 0.00
Evolus (EOLS) United States $0.325B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.309B 0.00
TriSalus Life Sciences (TLSI) United States $0.291B 0.00
Viemed Healthcare (VMD) United States $0.277B 22.06
TerrAscend (TSNDF) Canada $0.243B 0.00
Aurora Cannabis (ACB) Canada $0.241B 142.00
Sanuwave Health (SNWV) United States $0.241B 0.00
High Tide (HITI) Canada $0.228B 0.00
Organigram Global (OGI) Canada $0.218B 0.00
Owens & Minor (OMI) United States $0.217B 2.17
Sanara MedTech (SMTI) United States $0.206B 0.00
Accendra Health (ACH) United States $0.200B 2.00
Vireo Growth (VREOF) United States $0.197B 0.00
OraSure Technologies (OSUR) United States $0.193B 0.00
Utah Medical Products (UTMD) United States $0.189B 16.64
Quipt Home Medical (QIPT) United States $0.159B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.145B 0.00
Apyx Medical (APYX) United States $0.144B 0.00
FitLife Brands (FTLF) United States $0.143B 0.00
Jushi Holdings (JUSHF) United States $0.120B 0.00
Fonar (FONR) United States $0.115B 16.77
Exagen (XGN) United States $0.115B 0.00
MacroGenics (MGNX) United States $0.113B 0.00
Biote (BTMD) United States $0.109B 4.76
Sharps Technology (STSS) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.060B 25.46
Nephros (NEPH) United States $0.047B 33.92
Cytosorbents (CTSO) United States $0.045B 0.00
Rockwell Medical (RMTI) United States $0.038B 0.00
Veru (VERU) United States $0.038B 0.00
Modular Medical (MODD) United States $0.036B 0.00
United-Guardian (UG) United States $0.029B 14.74
Jin Medical (ZJYL) China $0.026B 0.00
Allurion Technologies (ALUR) United States $0.016B 0.00
Cellectar Biosciences (CLRB) United States $0.016B 0.00
Bonk (BNKK) United States $0.015B 0.00
INLIF (INLF) China $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
IM Cannabis (IMCC) Canada $0.007B 0.00
Flora Growth (FLGC) United States $0.007B 0.00
Zynex (ZYXI) United States $0.004B 0.00
Agape ATP (ATPC) $0.004B 0.00
Functional Brands (MEHA) United States $0.003B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Meihua Medical Technologies (MHUA) China $0.002B 0.00
Akanda (AKAN) Canada $0.000B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 0.00